This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager.
Dismiss

Antitrust - AptarGroup - ARS Pharmaceuticals litigation over single-dose intranasal spray systems (US)

ARS Pharmaceuticals Operations filed a US complaint accusing AptarGroup of illegally limiting competition to its emergency-use, single-dose intranasal spray system through exclusionary policies to delay competitive entry and thereby extend its ability to overcharge for inputs.


To add details to this portfolio regarding legal or economic representatives, please contact editors@mlex.com.

Timeline

Parties

Get the inside track, with MLex

With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.


  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

TRY MLEX FREE FOR 14 DAYS